Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 16 de 16
Filter
1.
Schizophr Res ; 220: 300-310, 2020 06.
Article in English | MEDLINE | ID: mdl-32204971

ABSTRACT

Cognitive deficits are a fundamental feature of schizophrenia for which currently no effective treatments exist. This paper examines the possibility to use transcranial direct current stimulation (tDCS) to target cognitive deficits in schizophrenia as evidence from studies in healthy participants suggests that tDCS may improve cognitive functions and associated neural processes. We carried out a systematic review with the following search terms: 'tDCS', 'electric brain stimulation', 'schizophrenia', 'cognitive', 'cognition' until March 2019. 659 records were identified initially, 612 of which were excluded after abstract screening. The remaining 47 articles were assessed for eligibility based on our criteria and 26 studies were excluded. In addition, we compared several variables, such as online vs. offline-stimulation protocols, stimulation type and intensity on mediating positive vs. negative study outcomes. The majority of studies (n = 21) identified significant behavioural and neural effects on a range of cognitive functions (versus n = 11 with null results), including working memory, attention and social cognition. However, we could not identify tDCS parameters (electrode montage, stimulation protocol, type and intensity) that clearly mediated effects on cognitive deficits. There is preliminary evidence for the possibility that tDCS may improve cognitive deficits in schizophrenia. We discuss the rationale and strength of evidence for using tDCS for targeting cognitive deficits in schizophrenia as well as methodological issues and potential mechanisms of action.


Subject(s)
Schizophrenia , Transcranial Direct Current Stimulation , Cognition , Double-Blind Method , Humans , Prefrontal Cortex , Schizophrenia/complications , Schizophrenia/therapy
2.
J Biol Regul Homeost Agents ; 27(2): 589-94, 2013.
Article in English | MEDLINE | ID: mdl-23830408

ABSTRACT

Corticosteroids are therapeutic drugs widely used in cases of allergic, inflammatory and autoimmune diseases, but sometimes allergic hypersensitivity reactions have been reported as a rare adverse effect of the corticosteroids themselves. Moreover, glucocorticoids can induce gastric lesions; that’s why they are sometimes administered intravenously together with some drugs such as proton pump inhibitors (PPI) or inhibitors of histamine-2 receptors (antiH2) working as gastric protectors. Although it is difficult to establish which drug was responsible in case of hypersensitivity reactions, as hypersensitivity reactions following to the use of PPI or anti-H2 have been already described in literature. Here we describe two cases of immediate-type hypersensitivity triggered from the administration of a corticosteroid plus a gastroprotective agent and the diagnostic check up required in both these patients.


Subject(s)
Adrenal Cortex Hormones/adverse effects , Anaphylaxis/chemically induced , Drug Hypersensitivity/etiology , Histamine H2 Antagonists/adverse effects , Proton Pump Inhibitors/adverse effects , Adult , Anaphylaxis/diagnosis , Basophils/physiology , Female , Humans , Middle Aged , Omeprazole/adverse effects , Skin Tests
3.
Int Arch Allergy Immunol ; 160(3): 297-300, 2013.
Article in English | MEDLINE | ID: mdl-23095317

ABSTRACT

BACKGROUND: Chronic urticaria (CU) may affect up to 1% of the general population. Anisakis simplex hypersensitivity is frequent in areas where raw fish is consumed and A. simplex allergy represents a relevant cause of acute urticaria. We assessed the possible association between CU and A. simplex sensitization in an area where marinated fish is very frequently eaten. METHODS: A thorough history of CU was sought in 919 adults seen at the Allergy Center, Bari. CU patients and 187 controls underwent skin-prick testing with a commercial extract of A. simplex, and reactors were recommended a 6-month raw-fish-free diet regimen. Responders were followed after a further 3 months. RESULTS: Of 919 subjects, 213 (23%) met the criteria for CU and 106/213 (49.7%) were sensitized to A. simplex with a significant difference between patients aged >65 or <65 years (56 vs. 41%, respectively; p < 0.05). All patients hypersensitive to A. simplex were regular consumers of marinated fish. In a control population without CU, the prevalence of A. simplex sensitization was 16% (p < 0.001). The 6-month diet regimen led to the disappearance of urticaria in 82/106 cases (77%) versus 1/42 (2%) subjects who did not change their dietary habits (p < 0.001). All nonresponders were sensitized to house-dust mites. Of 75 responders who were followed-up after 3 months, CU relapsed in 88% of those who had reintroduced raw fish versus 14% of those who were still on the diet (p < 0.001). CONCLUSION: In areas where raw or marinated fish is frequently eaten, A. simplex hypersensitivity is a frequent cause of CU.


Subject(s)
Anisakis/immunology , Antigens, Helminth/immunology , Endemic Diseases/statistics & numerical data , Food Hypersensitivity/epidemiology , Urticaria/epidemiology , Adolescent , Adult , Age Factors , Aged , Aged, 80 and over , Animals , Antigens, Helminth/adverse effects , Chronic Disease , Endemic Diseases/prevention & control , Female , Fish Products/adverse effects , Follow-Up Studies , Food Hypersensitivity/diet therapy , Humans , Italy , Male , Middle Aged , Prevalence , Skin Tests , Urticaria/diet therapy , Young Adult
4.
Immunopharmacol Immunotoxicol ; 34(3): 530-3, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22124340

ABSTRACT

The guidelines for the management of urticaria in adults and children have been published in outstanding position papers. By contrast, the onset of urticaria in the elderly has not yet had a clear definition. In order to approach diagnosis and treatment in a population of elderly patients, we have performed an epidemiological study on a population of elderly people observed in the Immuno Allergology Unit in Bari University Hospital. The patients underwent skin prick test for food allergy and laboratory and instrumental tests. From the data it resulted that 49% of cases have had urticaria because of adverse drug reactions (ADRs), 16% of cases were positive to food, while in 21% of cases systemic and metabolic diseases (SMDs) have been diagnosed. If we consider the young controls, urticaria for ADR was present in 48% of cases; however, in 28% it was possible to make the diagnosis of food allergy, 12% cases had a SMD. Our results show that the main cause of urticaria in the elderly is related to drug assumption because of the high number of drugs taken, followed by internal pathologies correlated to the typical immune and metabolic changes of the elderly. Furthermore, from the observation of our data it was possible to give guidelines for the treatment of urticaria in geriatric age.


Subject(s)
Urticaria/epidemiology , Urticaria/etiology , Urticaria/therapy , Adult , Aged , Aged, 80 and over , Child , Child, Preschool , Drug Hypersensitivity/complications , Drug Hypersensitivity/epidemiology , Drug Hypersensitivity/therapy , Female , Food Hypersensitivity/complications , Food Hypersensitivity/epidemiology , Food Hypersensitivity/therapy , Humans , Male , Skin Tests
6.
Am J Transplant ; 9(2): 348-54, 2009 Feb.
Article in English | MEDLINE | ID: mdl-19120080

ABSTRACT

Renal dysfunction is a well-known complication following heart transplantation. We examined an early decline in kidney function as a predictor of progression to end-stage renal disease and mortality in heart transplant recipients. We performed a retrospective cohort study of 233 patients who received a heart transplant between July 1985 and July 2004, and who survived >1 month. The decline in estimated creatinine clearance (CrCl) was used to predict the outcomes of need for chronic dialysis or mortality >1-year posttransplant. The earliest time to chronic dialysis was 484 days. A 30% decline in CrCl between 1 month and 12 months predicted the need for chronic dialysis (p = 0.01), all-cause mortality (p < 0.0001) and time to first CrCl 1-year posttransplant (p = 0.02). A 30% decline in CrCl between 1 month and 3 months also independently predicted the need for chronic dialysis (p = 0.04) and time to first CrCl 1-year posttransplant (p = 0.01). In conclusion, an early drop in CrCl within the first year is a strong predictor of chronic dialysis and death >1-year postheart transplantation. Future studies should focus on kidney function preservation in those identified at high risk for progression to end-stage kidney disease and mortality.


Subject(s)
Heart Transplantation/physiology , Kidney/physiopathology , Postoperative Complications , Renal Insufficiency/physiopathology , Cohort Studies , Creatinine/urine , Female , Humans , Immunosuppressive Agents/therapeutic use , Male , Middle Aged , Renal Insufficiency/etiology , Renal Insufficiency/mortality , Retrospective Studies , Risk Factors , Survival Rate , Time Factors , Treatment Outcome
7.
Neurol Sci ; 28(2): 107-10, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17464476

ABSTRACT

We describe a follow-up study of a patient with a selective, progressive impairment of topographical orientation. The patient's topographical difficulties were evident only in unfamiliar surroundings at the beginning of the observation period but later on they were observed even at home. Serial neuropsychological tests demonstrated a progressive impairment of visuospatial abilities with sparing of the other cognitive domains; only at the last assessment, about six years after early disturbances and three years after the first evaluation, the patient developed the typical cognitive impairments of Alzheimer's disease (AD). This case represents a focal variant of AD not previously described and suggests that the neuronal pathways underlying spatial orientation may be selectively damaged by the degenerative process.


Subject(s)
Alzheimer Disease/physiopathology , Brain/physiopathology , Cognition Disorders/physiopathology , Confusion/physiopathology , Memory Disorders/physiopathology , Activities of Daily Living/psychology , Alzheimer Disease/diagnosis , Alzheimer Disease/psychology , Brain/pathology , Cognition/physiology , Cognition Disorders/etiology , Cognition Disorders/psychology , Confusion/etiology , Confusion/psychology , Disease Progression , Follow-Up Studies , Humans , Male , Memory/physiology , Memory Disorders/etiology , Memory Disorders/psychology , Middle Aged , Neural Pathways/physiopathology , Neuropsychological Tests , Orientation/physiology , Space Perception/physiology
9.
Transplant Proc ; 36(2 Suppl): 442S-447S, 2004 Mar.
Article in English | MEDLINE | ID: mdl-15041383

ABSTRACT

Therapeutic drug monitoring of CsA has evolved since the introduction of CsA microemulsion. The purpose of the present review is to summarize the history of CsA concentration 2 hours postdose (C2) monitoring in heart and liver transplantation. C2 has been shown to be the best single time point that correlates with the area-under-the-curve, with a correlation coefficient (r2) ranging between .83 and.93. C2 monitoring (300 to 600 ng/mL) has resulted in a significant clinical benefit in long-term heart and liver transplant patients compared to trough level (C0) monitoring. Moreover, a C2 range of 300 to 600 ng/mL resulted in a similar calcineurin inhibition compared to a C2 range of 700 to 1000 ng/mL or a C0 range of 100 to 200 ng/mL while being less injurious to renal function. In de novo liver transplant patients not receiving induction therapy, the achievement of a target C2 of 850 to 1400 ng/mL by postoperative day 3 has resulted in a low acute rejection rate. Furthermore, C2 monitoring has been associated with a lower rejection rate in hepatitis C virus (HCV)-negative patients and with an overall lesser severity of acute rejection compared to C0 monitoring. In de novo heart transplant patients who receive antithymocyte globulin induction, a lower C2 range may be sufficient to prevent rejection and renal dysfunction. Future studies should help to fine-tune the optimal C2 range in heart or liver transplant patients receiving induction therapy and different maintenance immunosuppressive combinations.


Subject(s)
Cyclosporine/therapeutic use , Heart Transplantation/physiology , Liver Transplantation/physiology , Administration, Oral , Calcineurin Inhibitors , Cyclosporine/administration & dosage , Cyclosporine/blood , Cyclosporine/history , Drug Monitoring/history , Emulsions , Heart Transplantation/immunology , History, 20th Century , Humans , Immunosuppressive Agents/administration & dosage , Immunosuppressive Agents/blood , Immunosuppressive Agents/therapeutic use , Liver Transplantation/immunology
12.
ASAIO J ; 46(5): 573-5, 2000.
Article in English | MEDLINE | ID: mdl-11016509

ABSTRACT

Adolescents with congestive cardiomyopathy who present with intractable arrhythmia or progressive ventricular failure have a very poor prognosis and often die awaiting cardiac transplantation (CTx). We present our recent experience with a pneumatically powered left ventricular assist device (LVAD) implanted emergently to salvage adolescents with severe biventricular failure. Four patients, aged 15-17 years, body surface areas of 1.5-1.7 m2, with dilated cardiomyopathy (LV diastolic dimension, 7.1-8.3 cm); two presented with cardiovascular collapse, one with refractory ventricular tachycardia, and one with cardiac arrest. Hemodynamic and biochemical data before and 1 week after LVAD placement are expressed as mean and range values. None of the patients required right ventricular assist, and all patients achieved functional recovery while on LVAD support (8-71 days). Currently, all four patients are alive (11-22 months) after successful CTx. We conclude that emergency implantation of an LVAD in adolescents with biventricular heart failure can be life saving. As has been shown in the adult population, such a ventricular assist system restores normal circulatory hemodynamics, reverses multi-organ dysfunction, and provides a "safe" bridge to transplantation.


Subject(s)
Heart Failure/surgery , Heart-Assist Devices , Adolescent , Emergencies , Humans , Male
13.
J Thorac Cardiovasc Surg ; 114(5): 727-35; discussion 735-7, 1997 Nov.
Article in English | MEDLINE | ID: mdl-9375602

ABSTRACT

BACKGROUND: Patients with pulmonary atresia, ventricular septal defect, and major aortopulmonary collateral arteries have traditionally required multiple unifocalization staging operations before undergoing complete repair. Recently, the feasibility of a single-stage unifocalization and repair was demonstrated by Hanley. In this report, we describe our experience with each approach. METHODS AND RESULTS: Since 1989, 11 of 12 patients with pulmonary atresia, ventricular septal defect, and major aortopulmonary collateral arteries have undergone complete surgical correction. The first seven patients were subjected to staged bilateral unifocalizations, with repair being achieved in six (group I). The last five patients have undergone a single-stage midline unifocalization and repair via a sternotomy (group II). Four of these were infants (2 weeks to 9 months) and one was 13 years old. All patients in group I had tetralogy of Fallot, whereas in group II three patients had tetralogy of Fallot, one patient had double-outlet right ventricle, and one patient had complete atrioventricular canal and transposition. In group I, the median age at the first operation was 43 weeks. Complete repair was performed at a median age of 3.5 years, with a mean number of 3.3 operations required. In group II, only one operation was required to achieve complete repair at a median age of 28 weeks. The postoperative right ventricular/left ventricular pressure ratio was 0.49 in group I and 0.45 in group II. One intraoperative death and one late death occurred in group I and no early or late deaths in group II. Currently, four patients in group I and all five patients in group II are alive and well. CONCLUSIONS: Early intervention with both surgical approaches can lead to complete biventricular repair in most patients. Because the single-stage midline unifocalization and repair can achieve a completely repaired heart in infancy with one operation, it is currently our approach of choice.


Subject(s)
Aorta, Thoracic/abnormalities , Heart Septal Defects, Ventricular/surgery , Pulmonary Artery/abnormalities , Pulmonary Atresia/surgery , Collateral Circulation/physiology , Female , Humans , Infant , Infant, Newborn , Male , Pulmonary Circulation/physiology , Sternum/surgery , Time Factors , Treatment Outcome
14.
Ann Thorac Surg ; 64(6): 1776-81, 1997 Dec.
Article in English | MEDLINE | ID: mdl-9436571

ABSTRACT

BACKGROUND: Patients with transposition complexes and aortic arch obstruction are a surgical challenge with significant mortality. We have adopted an aggressive approach of concurrent aortic arch repair and arterial switch operation with excellent results. METHODS: Since 1989, 12 of 13 patients with aortic arch obstruction and transposition of the great arteries or double-outlet right ventricle with subpulmonary ventricular septal defect have undergone complete single-stage repair. One patient underwent a two-stage repair because of hemodynamic instability. The median age of repair was 27 days and the median weight was 3.5 kg. Surgical technique involved the arterial switch operation and ventricular septal defect closure when present in 12 patients. One patient with severe subaortic stenosis underwent a modified Damus-Kaye-Stansel operation with concomitant aortic arch enlargement. The aortic arch was enlarged in 12 of 13 patients with a pulmonary homograft patch. RESULTS: There have been no early deaths and only one late death at 39 months postoperatively from hepatoblastoma. The mean follow-up is 42 months. There have been no reoperations for recurrent aortic arch obstruction. All survivors are currently well from a cardiac point of view. CONCLUSIONS: Concomitant single-stage repair for transposition complexes with aortic arch obstruction achieves excellent survival and should be the surgical procedure of choice.


Subject(s)
Aorta, Thoracic/surgery , Double Outlet Right Ventricle/surgery , Transposition of Great Vessels/surgery , Aortic Valve Stenosis/complications , Blood Vessel Prosthesis Implantation , Double Outlet Right Ventricle/complications , Female , Follow-Up Studies , Heart Septal Defects, Ventricular/complications , Heart Septal Defects, Ventricular/surgery , Humans , Infant , Infant, Newborn , Male , Methods , Transposition of Great Vessels/complications , Treatment Outcome
15.
J Card Surg ; 11(1): 75-8, 1996.
Article in English | MEDLINE | ID: mdl-8775341

ABSTRACT

A 40-year-old man with viral cardiomyopathy underwent uncomplicated dynamic cardiomyoplasty. On the third postoperative day, he was rescued from an 8-hour period of severe cardiogenic shock. Eleven days postoperatively, he was withdrawn and uncooperative, preferring to be left alone. He then complained of total blindness, which persisted to his sudden death on postoperative day 26. Clinical examination revealed no neurological abnormality except for signs consistent with a diagnosis of ischemic optic neuropathy. The optic nerve in the scleral canal is especially vulnerable to hypoperfusion. Blindness has been reported following severe hemorrhage, bilateral neck dissection, and has an incidence of 1 per 1100 cases following cardiopulmonary bypass. Anemia and hypotension may be consistent risk factors predisposing patients to this catastrophic complication.


Subject(s)
Blindness/etiology , Cardiomyoplasty , Postoperative Complications , Adult , Fatal Outcome , Humans , Male , Optic Neuropathy, Ischemic/etiology , Shock, Cardiogenic/etiology
16.
Can J Cardiol ; 11(5): 407-14, 1995 May.
Article in English | MEDLINE | ID: mdl-7750037

ABSTRACT

Many among the large and increasing number of patients suffering from heart failure can benefit from surgical interventions. The indications, efficacy and limitations of various surgical procedures currently available are reviewed, and an integrated approach to offer surgical therapy optimal for the particular patients is proposed.


Subject(s)
Cardiomyoplasty , Heart Failure/surgery , Heart Transplantation , Canada/epidemiology , Female , Heart Failure/epidemiology , Heart-Lung Machine , Humans , Male , Pacemaker, Artificial , Ventricular Dysfunction, Left/therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...